- Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naive Prostate Cancer: 1-and 2-Year Open-label Follow-up Results2015 | First Faculty of Medicine
- The role of ARTA in metastatic hormon-naive prostate cancer treatment2022 | Third Faculty of Medicine
- Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study2014 | First Faculty of Medicine, Third Faculty of Medicine
- Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naive Prostate Cancer: 3-Year Open Label Followup Results2018 | First Faculty of Medicine
- Treatment of lung metastases in prostate cancer - case reports2021 | Third Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No: 212082PCR3011Publication without faculty affiliation